Minoxidil vs TB-4 Topical (Hair)
A side-by-side research comparison of Minoxidil and TB-4 Topical (Hair) across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Minoxidil | TB-4 Topical (Hair) |
|---|---|---|
| Full name | Minoxidil (Rogaine) | Thymosin Beta-4 Topical (Hair Growth) |
| Category | Hair Growth | Hair Growth |
| Status | FDA Approved (OTC) | Research compound |
| Mechanism | Opens ATP-sensitive potassium channels in vascular smooth muscle and hair follicle cells. Increases blood flow and nutrient delivery to follicles. Prolongs anagen (growth) phase and stimulates VEGF expression for neovascularization around follicles. | Promotes migration and differentiation of hair follicle stem cells via actin sequestration and cell motility enhancement. Activates quiescent stem cells in the bulge niche. Stimulates new blood vessel formation around follicles for nutrient delivery. |
| Molecular weight | 209.25 Da | 4921 Da |
| Half-life | ~4 hours (systemic); active in follicle for 22h | ~6 hours (systemic); local depot effect (topical) |
| Bioavailability | ~95% oral; topical: local depot effect | Topical: penetrates to bulge region with microneedling |
| Typical dose | 5% topical (1mL 2x/day) or 2.5-5 mg oral | 50-200 mcg per scalp application or 0.1% solution |
| Frequency | Twice daily (topical) or once daily (oral) | 3x weekly |
| Route | Topical solution/foam or oral tablet | Topical serum or mesotherapy (intradermal injection) |
Minoxidil reported benefits
- Stimulates new hair growth
- Works independently of DHT pathway
- OTC availability
- Effective for both sexes
- Prolongs anagen phase
- Can combine with any other treatment
TB-4 Topical (Hair) reported benefits
- Hair follicle stem cell activation
- Dormant follicle reactivation
- Scalp angiogenesis
- Anti-inflammatory for scalp
- Synergistic with microneedling
- Novel mechanism (stem cell migration)
Related comparisons
Research and educational reference only. Not medical advice.